Sitemap > Breaking Research > Immunology & Inflammatory Diseases
Displaying 1451 - 1500 of 5698 results
- Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice.
- Identification of a potent and selective non-basic cathepsin K inhibitor.
- 1-Phenyl-8-azabicyclo[3.2.1]octane ethers: a novel series of neurokinin (NK1) antagonists.
- Effects of macrophage inducible nitric oxide synthase in murine septic lung injury.
- Transforming growth factor-beta1 increases airway wound repair via MMP-2 upregulation: a new pathway for epithelial wound repair?
- Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms.
- Expression of the reverse tetracycline-transactivator gene causes emphysema-like changes in mice.
- A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.
- Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood.
- NF-kappaB activation precedes increases in mRNA encoding neurokinin-1 receptor, proinflammatory cytokines, and adhesion molecules in dextran sulfate sodium-induced colitis in rats.
- Double-blind pilot study of mesalamine vs. placebo for treatment of chronic diarrhea and nonspecific colitis in immunocompetent HIV patients.
- Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury.
- A novel prostaglandin E receptor 4-associated protein participates in antiinflammatory signaling.
- The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.
- Formoterol, 24 microg bid, and serious asthma exacerbations: similar rates compared with formoterol, 12 microg bid, with and without extra doses taken on demand, and placebo.
- Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.
- Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.
- Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis.
- Toll-like receptor 4 plays an anti-HBV role in a murine model of acute hepatitis B virus expression.
- AEOL-10150 (Aeolus).
- BTLA, a new inhibitory B7 family receptor with a TNFR family ligand.
- FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration.
- The effect of CD3-specific monoclonal antibody on treating experimental autoimmune myasthenia gravis.
- RNA interference in immune cells by use of osmotic delivery of siRNA.
- Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.
- SMM-chemokines: a class of unnatural synthetic molecules as chemical probes of chemokine receptor biology and leads for therapeutic development.
- Synthesis and activity of a new class of pathway-selective estrogen receptor ligands: hydroxybenzoyl-3,4-dihydroquinoxalin-2(1H)-ones.
- MCI-186 (edaravone), a free radical scavenger, attenuates ischemia-reperfusion injury and activation of phospholipase A(2) in an isolated rat lung model after 18 h of cold preservation.
- Macrophage-secreted factors induce adipocyte inflammation and insulin resistance.
- HSV-1-mediated NGF delivery delays nociceptive deficits in a genetic model of diabetic neuropathy.
- Overview of common causes of chronic cough: ACCP evidence-based clinical practice guidelines.
- Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines.
- Chronic cough due to nonbronchiectatic suppurative airway disease (bronchiolitis): ACCP evidence-based clinical practice guidelines.
- Chronic cough due to chronic interstitial pulmonary diseases: ACCP evidence-based clinical practice guidelines.
- Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines.
- Potential future therapies for the management of cough: ACCP evidence-based clinical practice guidelines.
- Future directions in the clinical management of cough: ACCP evidence-based clinical practice guidelines.
- Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice.
- Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.
- In vivo treatment of mice with heat shock protein, gp 96, improves survival of skin grafts with minor and major antigenic disparity.
- Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity.
- In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
- Cannabinoid receptor type 2 agonists induce transcription of the mu-opioid receptor gene in Jurkat T cells.
- Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.
- Vascularized tissue-engineered chambers promote survival and function of transplanted islets and improve glycemic control.
- CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.
- Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo.
- Heart allograft protection with low-dose carbon monoxide inhalation: effects on inflammatory mediators and alloreactive T-cell responses.
- Lentiviral gene transfer of the chemokine antagonist RANTES 9-68 prolongs heart graft survival.
- CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | 107 | 108 | 109 | 110 | 111 | 112 | 113 | 114 Next >